Finance

Lists
Why is CTX down 2,29%?
Dive Deeper
CTX:WSE
Captor Therapeutics SA
64,00 PLN
-2,29%
(-1,50) 1D
9-окт., 17:00:00 GMT+2  ·   PLN
All symbols
SymbolPriceChange% Change
Generating top insights for CTX...
Open
65,40 PLN
High
66,70 PLN
Low
62,50 PLN
Mkt. cap
406,62 млн
Avg. vol.
3,27 миң
Volume
10,03 миң
52-wk high
89,20 PLN
52-wk low
37,70 PLN
EPS
-7,77 PLN
Shares outstanding
6,35 млн
No. of employees
82
Open
65,40 PLN
High
66,70 PLN
Low
62,50 PLN
Mkt. cap
406,62 млн
Avg. vol.
3,27 миң
Volume
10,03 миң
52-wk high
89,20 PLN
52-wk low
37,70 PLN
EPS
-7,77 PLN
Shares outstanding
6,35 млн
No. of employees
82
News stories
From web sources and news partners
About Captor Therapeutics SA
CEO-
Employees82
Founded2015
Headquarters-
Sector-
Last report
2026-ж., 15-сен.
Fiscal period
Q2 2026
- / -
Revenue / Est. (PLN)
1,63 млн / 1,50 млн
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in PLN
Loading Previous Earnings...
Revenue
Net income
All values in PLN
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
-
44,00 миң
328,00 миң
1,63 млн
Cost of goods sold
-2,02 млн
-
-
173,00 миң
Cost of revenue
-2,02 млн
-
-
173,00 миң
Research and development expenses
14,74 млн
9,82 млн
10,56 млн
13,78 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,37 млн
2,53 млн
1,92 млн
2,25 млн
Operating expense
13,83 млн
10,40 млн
11,59 млн
14,39 млн
Total operating expenses
11,81 млн
10,40 млн
11,59 млн
14,56 млн
Operating income
-11,81 млн
-10,36 млн
-11,26 млн
-12,93 млн
Other non operating income
1,00 миң
-8,00 миң
-
-
EBT including unusual items
-11,48 млн
-10,05 млн
-11,35 млн
-11,39 млн
EBT excluding unusual items
-11,48 млн
-10,12 млн
-11,35 млн
-11,39 млн
Income tax expense
-
-
27,00 миң
-
Effective tax rate
-
-
-0,24%
-
Other operating expenses
-2,27 млн
-1,94 млн
-893,00 миң
-1,64 млн
Net income
-11,48 млн
-10,05 млн
-11,38 млн
-11,39 млн
Net profit margin
-
-22 831,82%
-3 467,99%
-696,88%
Earnings per share
-
-
-
-
Interest and investment income
391,00 миң
303,00 миң
39,00 миң
1,63 млн
Interest expense
-61,00 миң
-75,00 миң
-67,00 миң
-57,00 миң
Net interest expenses
330,00 миң
228,00 миң
-28,00 миң
1,57 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
-10,81 млн
-9,53 млн
-10,36 млн
-12,04 млн
Gain or loss from assets sale
-682,00 миң
-
-
-128,00 миң
AI content may include mistakes. Learn more
Google колдонмолору